ArticleThe American journal of case reports2025
Endoscopic Vacuum Therapy for Anastomotic Leakage After Distal Gastrectomy in a Renal Transplant Patient: A Case Study.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- VacStent as a novel therapeutic approach for esophageal perforations and anastomotic leaks- a systematic review of the literature.BMC surgery · 2025Pooled it
- Analysis of quality of life and reflux oesophagitis following Billroth II and Roux-en-Y gastrointestinal reconstruction for gastric cancer.World journal of gastrointestinal surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Since the late 2000's, endoscopic vacuum therapy (EVT) has gained popularity in the management of anastomotic leakage (AL) of the upper gastrointestinal (GI) tract due to its safety and efficacy. This report describes a 66-year-old male renal transplant patient with an AL following distal gastrectomy for gastric adenocarcinoma and was treated with EVT. CASE REPORT We present the case of a 66-year-old transplant patient with multiple comorbidities who developed AL following distal gastrectomy for gastric adenocarcinoma. Before the scheduled operation, he had been deemed at high risk for AL due to immunosuppression, as well as his history of end-stage renal disease and multiple abdominal surgeries. After an initial failed attempt to treat the AL surgically, he became the first person to be treated with a self-assembled EVT in our hospital. He was successfully treated with EVT and was ultimately safely discharged. Also, 30 days after discharge, he did not report any discomfort or express any problems with oral intake of food, as supported by the findings of a follow-up endoscopy. CONCLUSIONS EVT is a reproducible technique, which when performed by experienced practitioners, remains effective even in the absence of prior experience with the procedure or even procedure-specific equipment. The technique shows promising outcomes in the management of AL and this case highlights the technique's effectiveness even in a patient with compromised wound healing in the presence of a hostile abdomen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.